The Patented Medicine Prices Review Board (PMPRB; French: Conseil d'examen du prix des médicaments brevetés) is a federal quasi-judicial regulatory and...
9 KB (781 words) - 00:57, 19 December 2024
Agency Canadian Institutes of Health Research Health Canada Patented Medicine Prices Review Board Public Health Agency of Canada As of 2023[update], the Health...
21 KB (1,571 words) - 00:17, 12 December 2024
Medication costs (redirect from Drug prices)
ISSN 0025-7079. PMID 11329519. Canada, Patented Medicine Prices Review Board (22 October 2020). "Patented Medicine Prices Review Board". www.canada.ca. Retrieved...
52 KB (5,905 words) - 21:20, 24 November 2024
Accountability (1993-02-22). "Prescription Drug Prices: Analysis of Canada's Patented Medicine Prices Review Board" (HRD-93-51). {{cite journal}}: Cite journal...
27 KB (3,002 words) - 18:00, 9 December 2024
pharmaceutical spending trends. In Canada, the Patented Medicine Prices Review Board (PMPRB) determines a maximum price for all drugs. In 1987, Bill C-22 established...
96 KB (11,761 words) - 03:41, 4 December 2024
Medication (redirect from Blockbuster medicine)
PPRS will be 4,75%. In Canada, the Patented Medicine Prices Review Board examines drug pricing and determines if a price is excessive or not. In these circumstances...
69 KB (7,421 words) - 03:50, 14 December 2024
""Highest International Price Comparison"" (HIPC). In June 2015, the Patented Medicine Prices Review Board (PMPRB) under the Canadian Patent Act, held a preliminary...
44 KB (3,805 words) - 09:19, 27 November 2024
Formulary (pharmacy) (redirect from National essential medicines list)
Formularies in Canada – Part 1: General Overview" (PDF). Patented Medicine Prices Review Board. October 2017. ISBN 978-0-660-09799-2. Allin, Sara; Marchildon...
13 KB (1,405 words) - 08:29, 27 October 2024
National Research Council of Canada National Energy Board Patented Medicine Prices Review Board Shared Services Canada Canadian Institutes of Health...
6 KB (612 words) - 19:36, 30 October 2024
Council for Canada Cabinet of Canada Treasury Board of Canada Canada School of Public Service Treasury Board Secretariat Privy Council Office Intergovernmental...
29 KB (713 words) - 06:13, 14 September 2024
Pharmaceutical policy (section Patent law)
at "reasonable prices". In Canada, the Patented Medicine Prices Review Board examines drug pricing, compares the proposed Canadian price to that of seven...
15 KB (2,207 words) - 17:00, 6 April 2024
of Canada; Canadian Institutes of Health Research; the Patented Medicine Prices Review Board; and the Canadian Food Inspection Agency Additionally, Health...
20 KB (1,805 words) - 00:53, 21 October 2024
atorvastatin was revised in 2009 to 20mg. The Canadian Patented Medicine Prices Review Board analysed the use of DDD for drug utilisation and cost analysis...
11 KB (1,670 words) - 16:16, 11 December 2021
compliance undertaking of Bausch Health, Canada Inc. to the Patented Medicine Prices Review Board". Government of Canada. 4 January 2023. Retrieved 16 January...
4 KB (271 words) - 22:40, 31 May 2024
Comparison of the healthcare systems in Canada and the United States (section Price of health care and administration overheads)
allowing the relative prices of therapeutically similar drugs to be considered in context. The Canadian Patented Medicine Prices Review Board also has the authority...
128 KB (14,358 words) - 18:00, 9 December 2024
Their prices are controlled by the Patented Medicine Prices Review Board (PMPRB). The PMPRB's pricing formula ensures that Canada pays prices based on...
72 KB (8,555 words) - 10:16, 20 December 2024
health driven business model aims to lower the prices of HIV, tuberculosis and hepatitis C medicines and facilitate the development of better-adapted...
17 KB (1,666 words) - 17:50, 23 January 2024
Insulin (medication) (category Wikipedia medicine articles ready to translate)
price. Canada, like many other industrialized countries, has price controls on the cost of pharmaceuticals. The Patented Medicine Prices Review Board...
108 KB (11,467 words) - 07:25, 14 November 2024
and non-obvious. A patent is the right to exclude others, for a limited time (usually, 20 years) from profiting from a patented technology without the...
36 KB (4,052 words) - 16:34, 20 October 2024
Apotex (section International access to medicine)
antidepressant originally patented by GlaxoSmithKline. Apotex launched their generic version of Paxil "at risk", meaning before patent litigation between Apotex...
34 KB (3,490 words) - 02:34, 25 November 2024
Standardization, and was observed by representatives from the Patented Medicine Prices Review Board and the Canadian Agency for Drugs and Technologies in Health...
13 KB (996 words) - 17:48, 19 May 2024
Novartis v. Union of India & Others (category Indian patent case law)
across the world". 3 April 2013. "Patented drugs must be priced smartly". Archived from the original on 5 April 2013. Patent with a purpose, Prof. Shamnad...
43 KB (5,300 words) - 23:28, 21 October 2024
competitors from performing tests required for FDA approval using patented methods, until the patents expired. In response, the Hatch-Waxman Act was negotiated...
14 KB (1,485 words) - 06:38, 30 July 2023
Imatinib (category Wikipedia medicine articles ready to translate)
PMID 23327457. Archived from the original on 24 July 2015. Patented Medicine Review Board. "Report on New Patented Drugs – Gleevec". Canada. Archived from the original...
71 KB (6,702 words) - 05:32, 9 August 2024
Parliament of Canada Canadian Institutes of Health Research Patented Medicine Prices Review Board Public Health Agency of Canada Canadian Food Inspection...
4 KB (140 words) - 23:12, 12 September 2024
Sildenafil (category Wikipedia medicine articles ready to translate)
treatment in pulmonary arterial hypertension: a systematic review". Respiratory Medicine. 108 (3): 531–7. doi:10.1016/j.rmed.2014.01.003. PMID 24462476...
83 KB (7,404 words) - 21:59, 23 November 2024
Bayh–Dole Act (redirect from Patent and Trademark Law Amendments Act)
the prices in other high income countries. The NIH held that "the extraordinary remedy of march-in was not an appropriate means for controlling prices."...
40 KB (4,623 words) - 22:54, 30 October 2024
Epinephrine autoinjector (category Social problems in medicine)
which end of the device contains the needle. The European Medicines Agency conducted a review of the safety of devices then on the market and found several...
57 KB (5,826 words) - 06:33, 24 November 2024
Robin Feldman (section Public Database of Drug Patents)
Drug Prices and Drug Wars: How Big Pharma Raises Prices and Keeps Generics off the Market outline how pharmaceutical companies maneuver using patent laws...
16 KB (1,355 words) - 13:40, 20 August 2024
of prices between the proprietary drug and the generic drug. Since 2010, numerous pharmaceutical board busters have started to become off-patent. As...
41 KB (3,595 words) - 21:42, 3 November 2024